TAFAMIDIS MEGLUMINE

4834 reported adverse events

These side effects are most commonly reported by patients taking TAFAMIDIS MEGLUMINE:

# Side effect Count
0 DEATH 1404
1 CARDIAC FAILURE 537
2 OFF LABEL USE 417
3 DYSPNOEA 240
4 CARDIAC FAILURE CHRONIC 194
5 PRODUCT USE IN UNAPPROVED INDICATION 190
6 ATRIAL FIBRILLATION 182
7 FATIGUE 174
8 CONDITION AGGRAVATED 159
9 DISEASE PROGRESSION 146
See all common reactions for TAFAMIDIS MEGLUMINE

TAFAMIDIS MEGLUMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEREDITARY NEUROPATHIC AMYLOIDOSIS 15 0.2778
1 CARDIAC AMYLOIDOSIS 89 0.0808
2 CARDIAC FAILURE CHRONIC 194 0.0455
3 AMYLOIDOSIS 40 0.0232
4 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 26 0.0185
5 ACQUIRED HAEMOPHILIA 12 0.0120
6 LEFT ATRIAL DILATATION 12 0.0094
7 LEFT VENTRICULAR HYPERTROPHY 35 0.0082
8 CARDIAC FAILURE 537 0.0067
9 BRAIN NATRIURETIC PEPTIDE INCREASED 17 0.0055
See all enriched reactions for TAFAMIDIS MEGLUMINE